ABBOTT LABORATORIES (ABT)
US0028241000 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to ABT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 129.28. This target is 20.74% above the current price.
ABT was analyzed by 29 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ABT.
In the previous month the buy percentage consensus was at a similar level.
ABT was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-22 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-04 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-04-03 | Citigroup | Maintains | Buy -> Buy |
| 2024-02-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-26 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-01-25 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-03 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-12-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-10-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-10-19 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-10-19 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-24 | Barclays | Maintains | Overweight -> Overweight |
| 2023-07-21 | Wolfe Research | Upgrade | Underperform -> Peer Perform |
| 2023-07-21 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-04-20 | UBS | Maintains | Buy |
| 2023-04-20 | Barclays | Maintains | Overweight |
| 2023-04-20 | Raymond James | Maintains | Outperform |
| 2023-04-20 | Citigroup | Maintains | Buy |
| 2023-04-17 | BTIG | Maintains | Buy |
| 2023-04-17 | Raymond James | Maintains | Outperform |
| 2023-04-10 | Wells Fargo | Maintains | Overweight |
| 2023-04-05 | Wells Fargo | Maintains | Overweight |
| 2023-01-27 | Barclays | Maintains | Overweight |
| 2023-01-26 | Bernstein | Maintains | Outperform |
| 2023-01-26 | Stifel | Maintains | Buy |
| 2023-01-26 | Raymond James | Maintains | Outperform |